Keros Therapeutics, Inc. (KROS)

Keros Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	690.22	559.93	331.15	279.05	230.04	265.88
Cash & Short-Term Investments	690.22	559.93	331.15	279.05	230.04	265.88
Cash Growth	70.06%	69.09%	18.67%	21.30%	-13.48%	3687.41%
Accounts Receivable	15.82	2.74	0.14	-	18	-
Other Receivables	1.92	1.71	0.95	0.84	0.2	0.22
Receivables	17.74	4.46	1.09	0.84	18.2	0.22
Prepaid Expenses	5.56	1.73	1.64	2.28	1.38	0.97
Other Current Assets	19.3	22.77	13.42	3.6	1.82	0.66
Total Current Assets	732.81	588.89	347.29	285.77	251.44	267.73
Property, Plant & Equipment	22.91	23.49	19.47	17.57	2.4	1.6
Other Long-Term Assets	1.45	3.51	3.26	3.45	1.41	0.12
Total Assets	757.17	615.89	370.03	306.78	255.25	269.44
Accounts Payable	5.27	4.6	5.45	3.34	3.65	2.15
Accrued Expenses	19.62	20.45	17.25	12	7.03	4.21
Current Portion of Leases	2.23	1.98	1.01	0.46	0.86	0.42
Current Income Taxes Payable	6.32	-	-	-	0.11	0.19
Current Unearned Revenue	0.93	-	-	-	-	-
Other Current Liabilities	0.35	0.42	0.67	0.75	0.2	0.22
Total Current Liabilities	34.71	27.45	24.37	16.55	11.85	7.18
Long-Term Leases	15.72	16.88	13.44	12.81	0.23	0.48
Other Long-Term Liabilities	-	-	-	-	-	0.06
Total Liabilities	50.43	44.33	37.81	29.36	12.08	7.72
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	1,158	1,140	713.64	505.86	366.93	326.73
Retained Earnings	-451.02	-568.78	-381.43	-228.43	-123.76	-65.01
Total Common Equity	706.73	571.55	332.21	277.42	243.17	261.72
Shareholders' Equity	706.73	571.55	332.21	277.42	243.17	261.72
Total Liabilities & Equity	757.17	615.89	370.03	306.78	255.25	269.44
Total Debt	17.95	18.86	14.44	13.27	1.09	0.9
Net Cash (Debt)	672.26	541.07	316.7	265.78	228.95	264.98
Net Cash Growth	71.54%	70.84%	19.16%	16.09%	-13.60%	33483.90%
Net Cash Per Share	16.78	14.45	10.75	10.53	9.81	17.09
Filing Date Shares Outstanding	40.62	40.56	35.98	28.54	24	23.27
Total Common Shares Outstanding	40.62	40.55	31.84	27.54	23.97	23.19
Working Capital	698.1	561.44	322.92	269.22	239.59	260.54
Book Value Per Share	17.40	14.09	10.43	10.07	10.14	11.28
Tangible Book Value	706.73	571.55	332.21	277.42	243.17	261.72
Tangible Book Value Per Share	17.40	14.09	10.43	10.07	10.14	11.28
Machinery	-	7.19	5.85	2.97	1.92	1.19
Leasehold Improvements	-	-	-	0.21	0.26	0.26

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q